Clinical Trials Directory

Trials / Unknown

UnknownNCT02635451

The Relation Between Serum Ascorbic Acid Concentration and Preterm Premature Rupture of Membranes

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Ain Shams Maternity Hospital · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

To study the association between maternal serum vitamin C concentration in women with preterm premature rupture of membranes (PPROM) and women without PPROM.

Detailed description

The micronutrient vitamin C is an effective water soluble antioxidant that scavenges several reactive oxygen species, thus reducing oxidative stress, It also acts as an enzymatic cofactor to the enzymes lysyl hydroxylase and prolyl hydroxylase, which is required for synthesis of hydroxyproline and hydroxylysine, Collagen requires hydroxyproline bridges across the triple helix to provide stability to it, Ascorbic acid also causes down regulation of the metalloproteinase-2 and biosynthesis of collagen where it is required for the formation of triple helical structure of collagen. Thus, ascorbic acid participates in the equilibrium between synthesis and degradation of collagen and this may be critical in reducing the occurrence of preterm PROM.

Conditions

Timeline

Start date
2016-01-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2015-12-18
Last updated
2015-12-18

Source: ClinicalTrials.gov record NCT02635451. Inclusion in this directory is not an endorsement.

The Relation Between Serum Ascorbic Acid Concentration and Preterm Premature Rupture of Membranes (NCT02635451) · Clinical Trials Directory